Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Concentrations: Measurements01:23

Drug Concentrations: Measurements

1.7K
Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma...
1.7K
Protein-Drug Binding: Determination Methods01:22

Protein-Drug Binding: Determination Methods

810
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
810
Measurement of Bioavailability: Pharmacokinetic Methods01:30

Measurement of Bioavailability: Pharmacokinetic Methods

526
Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...
526
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

1.0K
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
1.0K
Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

357
The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
357
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

346
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
346

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A cryopreserved and <i>in vivo-in vitro</i> validated human induced pluripotent stem cell blood-brain barrier model for reliable neurotoxicity assessment.

NAM journal·2026
Same author

Corrigendum to "Clinical assessment and acceptance criteria for continuous glucose monitoring (CGM) system performance: A proposed guideline by the IFCC working group on CGM" [Clin. Chim. Acta 580 (2026) 120728].

Clinica chimica acta; international journal of clinical chemistry·2026
Same author

[Gene doping: current test methods and analytical challenges].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Same author

Glucose Monitoring and Control Testing in Patients with Type 1 or Type 2 diabetes.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2026
Same author

Analysis and Characterization of Kisspeptin and Its Analogues in Serum and Urine Samples by Liquid Chromatography-High-Resolution Mass Spectrometry for Doping Control Purposes.

Drug testing and analysis·2026
Same author

Detection of the GH Analogue Redalsomatropin Alfa in Sports Drug Testing: Immunological Approaches and LC-HRMS/MS.

Drug testing and analysis·2026

Related Experiment Video

Updated: May 5, 2026

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones
06:06

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones

Published on: February 5, 2018

24.6K

Bioanalytical methods in doping controls: a review.

Andreas Thomas1, Katja Walpurgis1, Nana Naumann1

  • 1Institute of Biochemistry/Center for Preventive Doping Research, German Sport University Cologne, Cologne, Germany.

Bioanalysis
|February 7, 2025
PubMed
Summary
This summary is machine-generated.

Advanced analytical methods enhance doping control by keeping pace with pharmaceutical advancements. This review explores new strategies for detecting performance-enhancing drugs and methods, crucial for fair sports.

Keywords:
Sport drug testingbioanalysisdetection strategiesfuture challengesprohibited biomolecules

More Related Videos

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

9.6K
Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
10:13

Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs

Published on: November 8, 2024

2.0K

Related Experiment Videos

Last Updated: May 5, 2026

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones
06:06

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones

Published on: February 5, 2018

24.6K
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

9.6K
Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
10:13

Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs

Published on: November 8, 2024

2.0K

Area of Science:

  • Sports Science
  • Analytical Chemistry
  • Biotechnology

Background:

  • Doping analysis requires continuous updates to counter evolving performance-enhancing drugs and methods.
  • Recent advancements, especially in bioanalysis, have significantly improved detection capabilities.
  • The World Anti-Doping Agency (WADA) list of banned substances and methods serves as a benchmark for these developments.

Purpose of the Study:

  • To systematically review and examine novel analytical and technological approaches in doping analysis.
  • To highlight recent progress in bioanalytical techniques for detecting banned substances and methods.
  • To assess how new scientific developments can address the challenges in modern anti-doping efforts.

Main Methods:

  • Review of sophisticated new *in-vitro* models, including multi-compartment models.
  • Investigation of novel long-term metabolites for anabolic agents.
  • Analysis of the impact of genetic mutations on erythropoietin detection.
  • Exploration of new protein-based drugs targeting myostatin.
  • Application of molecular biology techniques for gene doping detection.
  • Development of new methods to uncover autologous blood transfusions.

Main Results:

  • Sophisticated *in-vitro* models offer improved simulation of physiological conditions for drug analysis.
  • Identification of new long-term metabolites aids in extending the detection window for anabolic agents.
  • Understanding genetic variations can refine the interpretation of doping tests, such as for erythropoietin.
  • Emerging protein therapeutics necessitate advanced analytical strategies.
  • Molecular biology tools provide new avenues for detecting gene doping.
  • Novel approaches enhance the detection of prohibited blood manipulations.

Conclusions:

  • Continuous innovation in analytical and technological approaches is vital for effective doping control.
  • The reviewed strategies represent significant progress in the ongoing effort to combat doping in sports.
  • These advancements are crucial for closing the gap between sophisticated cheating methods and robust sport drug testing.